Concepedia

Nanshi Sha

NS

4

Publications

136

Citations

4

H-Index

2013

Active since

Affiliations

Boehringer Ingelheim (United States)(Current)

University of Nottingham

Nanshi Sha is an author at Boehringer Ingelheim (United States) specializing in medicine, drug resistance, and hepatitis c.

Top concepts

Publications per year

2013–2021

4

Publications

4

Comparison of Long-term Ambulatory Function in Patients with Duchenne Muscular Dystrophy Treated with Eteplirsen and Matched Natural History Controls

Jerry R. Mendell, Navid Khan, Nanshi Sha et al. · Journal of Neuromuscular Diseases · 2021 · 48 citations · Full text

Discontinuation of Antiplatelet Study Medication and Risk of Recurrent Stroke and Cardiovascular Events: Results from the PRoFESS Study

Christian Weimar, Dan Cotton, Nanshi Sha et al. · Cerebrovascular Diseases · 2013 · 45 citations

Low Glomerular Filtration Rate, Recurrent Stroke Risk, and Effect of Renin–Angiotensin System Modulation

Bruce Ovbiagele, Philip M. Bath, Nanshi Sha et al. · Stroke · 2013 · 32 citations · Full text

Baseline Polymorphisms and Emergence of Drug Resistance in the NS3/4A Protease of Hepatitis C Virus Genotype 1 following Treatment with Faldaprevir and Pegylated Interferon Alpha 2a/Ribavirin in Phase 2 and Phase 3 Studies

Kristi L. Berger, Joseph Schérer, Mithun Ranga et al. · Antimicrobial Agents and Chemotherapy · 2015 · 11 citations · Full text

, , +18

Rows per page

1–4 of 4